Ignite Creation Date:
2024-05-05 @ 11:41 AM
Last Modification Date:
2024-10-26 @ 9:11 AM
Study NCT ID:
NCT00100672
Status:
COMPLETED
Last Update Posted:
2011-07-04
First Post:
2005-01-04
Brief Title:
Study to Determine the Maximum Tolerated Dose of LErafAON in Patients With Advanced Cancer
Sponsor:
INSYS Therapeutics Inc
Organization:
INSYS Therapeutics Inc
Organization Data
Organization:
INSYS Therapeutics Inc
Class:
INDUSTRY
Study ID:
LErafAON-ETU-104-R02
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
INSYS Therapeutics Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None